Tenth International AFMBioMed Conference on AFM in Life Sciences and Medicine, August 30–September 2, 2022, Nagoya-Okasaki, Japan

IF 2.3 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Journal of Molecular Recognition Pub Date : 2024-02-27 DOI:10.1002/jmr.3077
Takayuki Uchihashi, Felix Rico, Jean-Luc Pellequer
{"title":"Tenth International AFMBioMed Conference on AFM in Life Sciences and Medicine, August 30–September 2, 2022, Nagoya-Okasaki, Japan","authors":"Takayuki Uchihashi,&nbsp;Felix Rico,&nbsp;Jean-Luc Pellequer","doi":"10.1002/jmr.3077","DOIUrl":null,"url":null,"abstract":"<p>Founded in June 2006, after a first seminal French-speaking conference held on the topic “Atelier Nanobiosciences: protéines et membranes” in <i>Nîmes</i> in June 2004, the AFMBioMed Conference brings researchers and students from around the world together to discuss the latest scientific results of atomic force microscopy in life sciences and medicine.<span><sup>1, 2</sup></span> A full account of the AFMBioMed history can be found here.<span><sup>3</sup></span> AFMBioMed organized its first international meeting in <i>Barcelona</i>, Spain, in spring 2007<span><sup>4</sup></span> and this was followed, at 18-month intervals, by <i>Monterey</i>, CA, USA, in fall 2008,<span><sup>5</sup></span> <i>Crveni otok</i> (Red Island) near the Adriatic City of Rovinj, Croatia, in spring 2010,<span><sup>6</sup></span> <i>Paris</i> in summer 2011,<span><sup>7</sup></span> <i>Shanghai</i> in spring 2013,<span><sup>8</sup></span> <i>San Diego</i> in fall 2014,<span><sup>9</sup></span> <i>Porto</i> in spring 2016,<span><sup>10</sup></span> <i>Krakow</i> in fall 2017,<span><sup>3</sup></span> and <i>Münster</i> in fall 2019.<span><sup>11</sup></span></p><p>Members of the scientific committee for the tenth edition of the AFMBioMed meeting in Nagoya-Okasaki, Japan, in summer 2022 include past and present organizers <i>Takayuki Uchihashi</i> (Nagoya University, Japan), <i>Hermann Schillers</i> (University of Münster, Germany), <i>Malgorzata Lekka</i> (Polish Academy of Sciences, Poland), <i>Susana R. Sousa</i> (i3S|INEB, Porto, Portugal), <i>Adam Engler</i> (UCSD, San Diego, USA), <i>Jun Hu</i> (SINAP, Shanghai, China), <i>Sanjay Kumar</i> (University of California, Berkeley, USA), <i>Daniel Navajas</i> (Universitat de Barcelona, Barcelona, Spain), <i>Simon Scheuring</i> (Institut National de la Santé et de la Recherche Médicale (INSERM) U1006, Marseille, France), <i>Vesna Svetlicic</i> (Rudjer Boskovic Institute, Zagreb, Croatia), the original founders of the conference <i>Pierre Parot</i> (IACA) and <i>Jean-Luc Pellequer</i> (CEA/DRF, Institut de Biologie Structurale, Grenoble, France), as well as the four invited chairs: <i>Alice Pyne</i> (Sheffield University, UK), <i>Felix Rico</i> (Aix-Marseille University—INSERM, France), <i>Takaharu Okajima</i> (Hokkaido University, Japan), and <i>Noriyuki Kodera</i> (Kanazawa University, Japan).</p><p>The 10th AFMBioMed was scheduled as a landmark conference. Despite the round number 10, it was the last conference organized with a single AFM sponsor (more below). It should have been the last conference that Pierre Parot, the co-founder of AFMBioMed, would participate in. At the end of the 9th conference in Münster, the 10th AFMBioMed conference was initially planned for spring 2021, the cherry blossom season in Japan. Unfortunately, the COVID-19 pandemic modified our plan. The conference was postponed every 6 months while waiting for the reopening of travel to Japan (as well as other countries). In early 2022, the organizing committee rejected the idea of organizing another online conference and we placed all our hope on the end of summer 2022. Because of the uncertainty of this period, Pierre Parot was not able to attend this conference. It is a sad follow-up to announce that Pierre died in 2023 at the age of 73.</p><p>Pierre Parot (1950–2023) was an unusual researcher. Pierre was recruited as an Engineer at Commissariat à l'Energie Atomique (CEA)-Leti (Grenoble) in 1977, after 2 years as an Assistant at the Université des Sciences et Techniques du Languedoc, where he defended his thesis in Solid State Physics (Montpellier 1976) on the study of Metal-Solvent-Semiconductor structures by thermal stimulation methods, and a post-doctoral stay in Giessen (Germany). Since then, his professional activities focused mainly on medical and scientific instrumentation and fundamental research in biophysics, a field in which Pierre defended a “thèse d'état” (Marseille 1987) on structural and dynamic studies of pigment-protein complexes in photosynthetic bacteria. He continued to work on electron transfer in the bioenergetic chain as his main research topic at CEA-Cadarache (1983–1995). After a sabbatical leave as Associate Professor in a research laboratory at the University of Connecticut at Storrs (USA, 1989–1990), Pierre realized the importance of developing relations between the CEA and the University. He proposed a collaboration in the field of Bioenergetics and created a joint CEA-Université de la Méditerranée laboratory at Luminy (LBTE, 1996–2001). This personal initiative was supported by those who, long after Newton and Pasteur, believe that there are more wall-builders than bridge-builders.</p><p>After a serious assessment of this enriching adventure, Pierre decided that the experiment, though successful, should not be prolonged. He returned to the CEA Valrhô, at Marcoule, as part of a new scientific project. He joined the Service de Biochimie post-génomique et Toxicologie Nucléaire (SBTN), a new scientific venture of CEA in which a research unit was built from the ground up. During the installation phase, Pierre created a biophysics group specializing in near-field microscopy: Atomic Force Microscopy (AFM) for biological studies. At the time, AFM had a very poor image among decision-makers, disillusioned by unsuccessful prior attempts in life sciences in the 1990s. However, results in late 1990s obtained on native membranes of purple bacteria—a field in which Pierre had worked for a long time—convinced us (PP + JLP) of the extraordinary potential of this instrument. We quickly set ourselves the dual objective of obtaining images of isolated single molecules and understanding the mechanisms of protein–protein interactions, and most importantly protein–metal interactions, one of the priority objectives of the CEA nuclear toxicology program. With the creation of institutes of the CEA Life Sciences division (DSV) in January 2007, the group became the Molecular Interactions and Recognition Laboratory (LIRM), headed by JLP. Pierre Parot was a cornerstone of both the AFMBioMed conferences and summer schools. His contribution to the success of AFMBioMed and beyond will be remembered.\n </p><p>Bruker had been the platinum sponsor of the AFMBioMed conference since 2007. The 10th conference was the last episode in this series. We are grateful for this long-term support from Bruker and their belief that AFM in life sciences is an important contribution to the field of Scanning Probe Microscopies. Among the Bruker-JPK's local organizers in the 2022 conference, we would like to acknowledge <i>Carmen Petterson</i> and <i>Oilibhe Pabsch</i>, as well as the congress office, namely, <i>Nao Morihashi</i> and <i>Tetsunari Kawaguchi</i>.</p><p>Other financial contributions from Wiley and Nagoya University are gratefully acknowledged.</p><p>The 2022 program featured three keynote and eight invited lectures by internationally renowned speakers, 58 oral presentations, and 28 poster presentations, with a total of 114 participants. The 2022 program also featured geographic diversity, with presentations from 18 countries on three continents!</p><p>Specialists from diverse fields, including cell biology, medicine, materials science, and physics, convened for both oral and poster presentations. These discussions centered on the latest technological advances and applications of AFM in areas such as Cell and Tissue Mechanics, Imaging and Force Measurement, and Novel Technology and Theory. Notable contributions included keynote lectures from <i>Simon Scheuring</i> (Cornell University, USA) and <i>Hirofumi Yamada</i> (Kyoto University, Japan). Invited talks were presented by <i>Roderick Lim</i> (University of Basel, Switzerland), <i>Adam J. Engler</i> (University of California, San Diego, USA), <i>Thomas Perkins</i> (JILA, NIST, University of Colorado, USA), and <i>Florence Tama</i> (Nagoya University, RIKEN, Japan). The sessions were chaired by <i>Takaharu Okajima</i> (Hokkaido University, Japan), <i>Felix Rico</i> (Aix-Marseille University, CNRS, INSERM, LAI, France), <i>Noriyuki Kodera</i> (Kanazawa University, Japan), and <i>Alice L.B. Pyne</i> (University of Sheffield, UK), who also gave a chairperson's lecture.</p><p>A special feature of the meeting was an online keynote lecture by <i>Cyrus Mody</i> (Maastricht University, the Netherlands), who discussed the state of scientific meetings in the post-COVID era. The keynote was followed by a fruitful discussion based on a questionnaire collected in advance from all participants.</p><p>The following three individuals were selected in the order mentioned below for the Best Poster Presentation Awards and were presented with prizes from Bruker: <i>Shigetaka Nishiguchi</i> (Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Japan), <i>Sabrina Horn</i> (Institute of Molecular Pathology (IMP), Austria), and <i>Irma Custovic</i> (Université Bourgogne Franche-Comté, France).</p><p>The best oral presentation award was selected from each session and the AFMBioMed-JMR Young Investigator Awards were presented to: <i>Kenichi Umeda</i> (Kanazawa University, Japan), <i>Nelmary Roas-Escalona</i> (Aalto University, Finland), <i>Constanca Caldeira Junior</i> (The Barcelona Institute of Science and Technology, Spain), and <i>Christian Ganser</i> (Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Japan).</p><p>In addition, in order to encourage young researchers to participate in the conference, a “Young Researcher Travel Award” was established to provide up to 500 USD per person for travel expenses, which was awarded to the following nine researchers: <i>Irma Custovic</i> (Université Bourgogne Franche-Comté, France), <i>You-Rong Lin</i> (Kanazawa University, Japan), <i>Nelmary Roas-Escalona</i> (Aalto University, Finland), <i>Klara Strobl</i> (Universidad Autónoma de Madrid, Spain), <i>Misato Iwashita</i> (Korea Brain Research Institute, Republic of Korea), <i>Yuzhen Feng</i> (Zernike Instituut, Rijksuniversiteit Groningen, the Netherlands), <i>Samuel Leitao</i> (EPFL, Switzerland), <i>Jonathan Roth</i> (The State University of New Jersey, USA), and <i>Xiaobin Yao</i> (Friedrich Schiller University Jena, Germany).</p><p>The conference also featured a half-day pre-conference Bruker Workshop and Training Day at AFM BioMed Conference 2022. A highlight of the conference was a visit to Gamagori City, located adjacent to Okazaki City. Attendees explored Takeshima, known as a spiritual spot, and strolled along the coastline, culminating in a banquet dinner at the historical Gamagori Classic Hotel. Bruker also sponsored a dinner at the restaurant “AQUA GARDEN GEIHINKAN OKAZAKI” on the second night as a Bruker Dinner.</p><p>We wish to thank all the contributors to this Special Collection and more particularly the reviewers that participated in the rigorous peer review of the submitted manuscripts. We are glad to announce that the 11th AFM BioMed Conference will take place in Barcelona. The location is reminiscent of the birthplace of the conference in 2007 and, indeed, what better choice for a complete regeneration of the conference with a totally renewed organizational concept. We are looking forward to seeing you in Barcelona in spring 2025!</p><p>Takayuki Uchihashi: writing-review and editing (equal). Felix Rico: writing-review and editing (supporting). Jean-Luc Pellequer: writing-review and editing (lead).</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":16531,"journal":{"name":"Journal of Molecular Recognition","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmr.3077","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Recognition","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmr.3077","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Founded in June 2006, after a first seminal French-speaking conference held on the topic “Atelier Nanobiosciences: protéines et membranes” in Nîmes in June 2004, the AFMBioMed Conference brings researchers and students from around the world together to discuss the latest scientific results of atomic force microscopy in life sciences and medicine.1, 2 A full account of the AFMBioMed history can be found here.3 AFMBioMed organized its first international meeting in Barcelona, Spain, in spring 20074 and this was followed, at 18-month intervals, by Monterey, CA, USA, in fall 2008,5 Crveni otok (Red Island) near the Adriatic City of Rovinj, Croatia, in spring 2010,6 Paris in summer 2011,7 Shanghai in spring 2013,8 San Diego in fall 2014,9 Porto in spring 2016,10 Krakow in fall 2017,3 and Münster in fall 2019.11

Members of the scientific committee for the tenth edition of the AFMBioMed meeting in Nagoya-Okasaki, Japan, in summer 2022 include past and present organizers Takayuki Uchihashi (Nagoya University, Japan), Hermann Schillers (University of Münster, Germany), Malgorzata Lekka (Polish Academy of Sciences, Poland), Susana R. Sousa (i3S|INEB, Porto, Portugal), Adam Engler (UCSD, San Diego, USA), Jun Hu (SINAP, Shanghai, China), Sanjay Kumar (University of California, Berkeley, USA), Daniel Navajas (Universitat de Barcelona, Barcelona, Spain), Simon Scheuring (Institut National de la Santé et de la Recherche Médicale (INSERM) U1006, Marseille, France), Vesna Svetlicic (Rudjer Boskovic Institute, Zagreb, Croatia), the original founders of the conference Pierre Parot (IACA) and Jean-Luc Pellequer (CEA/DRF, Institut de Biologie Structurale, Grenoble, France), as well as the four invited chairs: Alice Pyne (Sheffield University, UK), Felix Rico (Aix-Marseille University—INSERM, France), Takaharu Okajima (Hokkaido University, Japan), and Noriyuki Kodera (Kanazawa University, Japan).

The 10th AFMBioMed was scheduled as a landmark conference. Despite the round number 10, it was the last conference organized with a single AFM sponsor (more below). It should have been the last conference that Pierre Parot, the co-founder of AFMBioMed, would participate in. At the end of the 9th conference in Münster, the 10th AFMBioMed conference was initially planned for spring 2021, the cherry blossom season in Japan. Unfortunately, the COVID-19 pandemic modified our plan. The conference was postponed every 6 months while waiting for the reopening of travel to Japan (as well as other countries). In early 2022, the organizing committee rejected the idea of organizing another online conference and we placed all our hope on the end of summer 2022. Because of the uncertainty of this period, Pierre Parot was not able to attend this conference. It is a sad follow-up to announce that Pierre died in 2023 at the age of 73.

Pierre Parot (1950–2023) was an unusual researcher. Pierre was recruited as an Engineer at Commissariat à l'Energie Atomique (CEA)-Leti (Grenoble) in 1977, after 2 years as an Assistant at the Université des Sciences et Techniques du Languedoc, where he defended his thesis in Solid State Physics (Montpellier 1976) on the study of Metal-Solvent-Semiconductor structures by thermal stimulation methods, and a post-doctoral stay in Giessen (Germany). Since then, his professional activities focused mainly on medical and scientific instrumentation and fundamental research in biophysics, a field in which Pierre defended a “thèse d'état” (Marseille 1987) on structural and dynamic studies of pigment-protein complexes in photosynthetic bacteria. He continued to work on electron transfer in the bioenergetic chain as his main research topic at CEA-Cadarache (1983–1995). After a sabbatical leave as Associate Professor in a research laboratory at the University of Connecticut at Storrs (USA, 1989–1990), Pierre realized the importance of developing relations between the CEA and the University. He proposed a collaboration in the field of Bioenergetics and created a joint CEA-Université de la Méditerranée laboratory at Luminy (LBTE, 1996–2001). This personal initiative was supported by those who, long after Newton and Pasteur, believe that there are more wall-builders than bridge-builders.

After a serious assessment of this enriching adventure, Pierre decided that the experiment, though successful, should not be prolonged. He returned to the CEA Valrhô, at Marcoule, as part of a new scientific project. He joined the Service de Biochimie post-génomique et Toxicologie Nucléaire (SBTN), a new scientific venture of CEA in which a research unit was built from the ground up. During the installation phase, Pierre created a biophysics group specializing in near-field microscopy: Atomic Force Microscopy (AFM) for biological studies. At the time, AFM had a very poor image among decision-makers, disillusioned by unsuccessful prior attempts in life sciences in the 1990s. However, results in late 1990s obtained on native membranes of purple bacteria—a field in which Pierre had worked for a long time—convinced us (PP + JLP) of the extraordinary potential of this instrument. We quickly set ourselves the dual objective of obtaining images of isolated single molecules and understanding the mechanisms of protein–protein interactions, and most importantly protein–metal interactions, one of the priority objectives of the CEA nuclear toxicology program. With the creation of institutes of the CEA Life Sciences division (DSV) in January 2007, the group became the Molecular Interactions and Recognition Laboratory (LIRM), headed by JLP. Pierre Parot was a cornerstone of both the AFMBioMed conferences and summer schools. His contribution to the success of AFMBioMed and beyond will be remembered.

Bruker had been the platinum sponsor of the AFMBioMed conference since 2007. The 10th conference was the last episode in this series. We are grateful for this long-term support from Bruker and their belief that AFM in life sciences is an important contribution to the field of Scanning Probe Microscopies. Among the Bruker-JPK's local organizers in the 2022 conference, we would like to acknowledge Carmen Petterson and Oilibhe Pabsch, as well as the congress office, namely, Nao Morihashi and Tetsunari Kawaguchi.

Other financial contributions from Wiley and Nagoya University are gratefully acknowledged.

The 2022 program featured three keynote and eight invited lectures by internationally renowned speakers, 58 oral presentations, and 28 poster presentations, with a total of 114 participants. The 2022 program also featured geographic diversity, with presentations from 18 countries on three continents!

Specialists from diverse fields, including cell biology, medicine, materials science, and physics, convened for both oral and poster presentations. These discussions centered on the latest technological advances and applications of AFM in areas such as Cell and Tissue Mechanics, Imaging and Force Measurement, and Novel Technology and Theory. Notable contributions included keynote lectures from Simon Scheuring (Cornell University, USA) and Hirofumi Yamada (Kyoto University, Japan). Invited talks were presented by Roderick Lim (University of Basel, Switzerland), Adam J. Engler (University of California, San Diego, USA), Thomas Perkins (JILA, NIST, University of Colorado, USA), and Florence Tama (Nagoya University, RIKEN, Japan). The sessions were chaired by Takaharu Okajima (Hokkaido University, Japan), Felix Rico (Aix-Marseille University, CNRS, INSERM, LAI, France), Noriyuki Kodera (Kanazawa University, Japan), and Alice L.B. Pyne (University of Sheffield, UK), who also gave a chairperson's lecture.

A special feature of the meeting was an online keynote lecture by Cyrus Mody (Maastricht University, the Netherlands), who discussed the state of scientific meetings in the post-COVID era. The keynote was followed by a fruitful discussion based on a questionnaire collected in advance from all participants.

The following three individuals were selected in the order mentioned below for the Best Poster Presentation Awards and were presented with prizes from Bruker: Shigetaka Nishiguchi (Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Japan), Sabrina Horn (Institute of Molecular Pathology (IMP), Austria), and Irma Custovic (Université Bourgogne Franche-Comté, France).

The best oral presentation award was selected from each session and the AFMBioMed-JMR Young Investigator Awards were presented to: Kenichi Umeda (Kanazawa University, Japan), Nelmary Roas-Escalona (Aalto University, Finland), Constanca Caldeira Junior (The Barcelona Institute of Science and Technology, Spain), and Christian Ganser (Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Japan).

In addition, in order to encourage young researchers to participate in the conference, a “Young Researcher Travel Award” was established to provide up to 500 USD per person for travel expenses, which was awarded to the following nine researchers: Irma Custovic (Université Bourgogne Franche-Comté, France), You-Rong Lin (Kanazawa University, Japan), Nelmary Roas-Escalona (Aalto University, Finland), Klara Strobl (Universidad Autónoma de Madrid, Spain), Misato Iwashita (Korea Brain Research Institute, Republic of Korea), Yuzhen Feng (Zernike Instituut, Rijksuniversiteit Groningen, the Netherlands), Samuel Leitao (EPFL, Switzerland), Jonathan Roth (The State University of New Jersey, USA), and Xiaobin Yao (Friedrich Schiller University Jena, Germany).

The conference also featured a half-day pre-conference Bruker Workshop and Training Day at AFM BioMed Conference 2022. A highlight of the conference was a visit to Gamagori City, located adjacent to Okazaki City. Attendees explored Takeshima, known as a spiritual spot, and strolled along the coastline, culminating in a banquet dinner at the historical Gamagori Classic Hotel. Bruker also sponsored a dinner at the restaurant “AQUA GARDEN GEIHINKAN OKAZAKI” on the second night as a Bruker Dinner.

We wish to thank all the contributors to this Special Collection and more particularly the reviewers that participated in the rigorous peer review of the submitted manuscripts. We are glad to announce that the 11th AFM BioMed Conference will take place in Barcelona. The location is reminiscent of the birthplace of the conference in 2007 and, indeed, what better choice for a complete regeneration of the conference with a totally renewed organizational concept. We are looking forward to seeing you in Barcelona in spring 2025!

Takayuki Uchihashi: writing-review and editing (equal). Felix Rico: writing-review and editing (supporting). Jean-Luc Pellequer: writing-review and editing (lead).

The authors declare no conflicts of interest.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
第十届 AFMBioMed 生命科学与医学原子力显微镜国际会议,2022 年 8 月 30 日至 9 月 2 日,日本名古屋-冈崎:纪念皮埃尔-帕罗(1950-2023 年)。
AFMBioMed 会议成立于 2006 年 6 月,是继 2004 年 6 月在尼姆举行的主题为 "Atelier Nanobiosciences:protéines et membranes "的首次法语会议之后的又一次重要会议,来自世界各地的研究人员和学生汇聚一堂,共同探讨原子力显微镜在生命科学和医学领域的最新科学成果。AFMBioMed 于 2007 年春季在西班牙巴塞罗那组织了首次国际会议4 ,随后每隔 18 个月分别于 2008 年秋季在美国加利福尼亚州蒙特雷、5 2010 年春季在克罗地亚亚得里亚海城市罗维尼附近的 Crveni otok(红岛)、6 2011 年夏季在巴黎、7 2013 年春季在上海、8 2014 年秋季在圣地亚哥、9 2016 年春季在波尔图、10 2017 年秋季在克拉科夫3 以及 2019 年秋季在明斯特举行会议。Sousa(i3S|INEB,葡萄牙波尔图)、Adam Engler(加州大学圣地亚哥分校,美国)、Jun Hu(中国国家信息安全研究院,中国上海)、Sanjay Kumar(加利福尼亚大学伯克利分校,美国)、Daniel Navajas(巴塞罗那大学,西班牙巴塞罗那)、Simon Scheuring(法国马赛国家健康与医学研究所(INSERM)U1006、法国马赛)、Vesna Svetlicic(克罗地亚萨格勒布 Rudjer Boskovic 研究所)、会议的最初发起人 Pierre Parot(国际宇航科学院)和 Jean-Luc Pellequer(法国格勒诺布尔 CEA/DRF,生物结构研究所)以及四位特邀主席:Alice Pyne(英国谢菲尔德大学)、Felix Rico(法国艾克斯-马赛大学-INSERM)、Takaharu Okajima(日本北海道大学)和 Noriyuki Kodera(日本金泽大学)。第 10 届 AFMBioMed 会议是一次具有里程碑意义的会议。尽管会议编号为 10,但它却是最后一次由 AFM 单个赞助商组织的会议(详情见下文)。它本应是 AFMBioMed 联合创始人皮埃尔-帕罗(Pierre Parot)参加的最后一次会议。在明斯特举行的第九届会议结束时,第十届 AFMBioMed 会议最初计划于 2021 年春季日本樱花盛开的季节举行。不幸的是,COVID-19 大流行改变了我们的计划。会议每 6 个月推迟一次,等待重新开放前往日本(以及其他国家)的旅行。2022 年初,组委会否决了再次组织在线会议的想法,我们将所有希望寄托在 2022 年夏末。由于这一时期的不确定性,皮埃尔-帕罗未能参加此次会议。皮埃尔-帕罗(Pierre Parot,1950-2023 年)是一位不同寻常的研究者。皮埃尔曾在朗格多克科学与技术大学(Université des Sciences et Techniques du Languedoc)担任过两年助教,并在该校通过了关于通过热刺激方法研究金属-溶剂-半导体结构的固体物理学论文答辩(蒙彼利埃,1976 年)。此后,他的专业活动主要集中在医疗和科学仪器以及生物物理的基础研究方面,在这一领域,皮埃尔通过了 "thèse d'état "答辩(1987 年,马赛),内容是光合细菌中色素-蛋白质复合物的结构和动态研究。1983-1995 年期间,皮埃尔在卡达拉什欧洲原子能机构(CEA-Cadarache)继续从事以生物能链中的电子传递为主要研究课题的工作。在美国康涅狄格大学 Storrs 分校的研究实验室担任副教授(1989-1990 年)期间,皮埃尔意识到发展 CEA 与该大学之间关系的重要性。他提议在生物能领域开展合作,并在卢米尼(Luminy)建立了法国原子能委员会-地中海大学联合实验室(LBTE,1996-2001 年)。皮埃尔的这一个人行动得到了牛顿和巴斯德之后的一些人的支持,他们认为 "筑墙者多于架桥者"。他回到了位于马尔库尔的瓦尔霍国家原子能委员会(CEA Valrhô),参与了一个新的科学项目。他加入了后基因组生物化学和核毒理学服务处(SBTN),这是法国原子能委员会的一项新的科学计划,从头开始建立一个研究单位。在安装阶段,皮埃尔创建了一个生物物理小组,专门从事近场显微镜研究:原子力显微镜(AFM)用于生物研究。当时,原子力显微镜在决策者心目中的形象很差,因为上世纪 90 年代,他们在生命科学领域的尝试都不成功。 然而,20 世纪 90 年代末在紫色细菌原生膜上获得的结果--皮埃尔曾在该领域工作过很长时间--使我们(PP + JLP)确信该仪器具有非凡的潜力。我们很快为自己设定了双重目标:获取分离的单分子图像,了解蛋白质与蛋白质之间的相互作用机制,最重要的是了解蛋白质与金属之间的相互作用机制,这是 CEA 核毒理学项目的优先目标之一。2007 年 1 月,随着法国原子能委员会生命科学部(DSV)研究所的成立,该小组成为分子相互作用与识别实验室(LIRM),由 JLP 领导。皮埃尔-帕罗是 AFMBioMed 会议和暑期班的基石。我们将铭记他为 AFMBioMed 及其他会议的成功做出的贡献。 布鲁克公司自 2007 年以来一直是 AFMBioMed 会议的白金赞助商。第 10 届会议是该系列会议的最后一届。我们非常感谢布鲁克公司的长期支持,感谢他们相信 AFM 在生命科学领域的应用是对扫描探针显微镜领域的重要贡献。在 2022 年会议的布鲁克-JPK 当地组织者中,我们要感谢 Carmen Petterson 和 Oilibhe Pabsch,以及大会办公室的 Nao Morihashi 和 Tetsunari Kawaguchi,感谢 Wiley 和名古屋大学的其他资助。2022 年会议还具有地域多样性的特点,有来自三大洲 18 个国家的代表在会上发言!来自细胞生物学、医学、材料科学和物理学等不同领域的专家在会上进行了口头和海报展示。这些讨论围绕原子力显微镜在细胞和组织力学、成像和力测量以及新型技术和理论等领域的最新技术进步和应用展开。Simon Scheuring(美国康奈尔大学)和 Hirofumi Yamada(日本京都大学)发表了主旨演讲。Roderick Lim(瑞士巴塞尔大学)、Adam J. Engler(美国加州大学圣迭戈分校)、Thomas Perkins(美国科罗拉多大学、NIST、JILA)和 Florence Tama(日本理化学研究所、名古屋大学)发表了特邀演讲。会议由 Takaharu Okajima(日本北海道大学)、Felix Rico(法国艾克斯-马赛大学、法国国家科学研究中心、法国国家医学研究中心、LAI)、Noriyuki Kodera(日本金泽大学)和 Alice L.B. Pyne(英国谢菲尔德大学)主持。会议的一大特色是 Cyrus Mody(荷兰马斯特里赫特大学)的在线主题演讲,他讨论了后 COVID 时代科学会议的现状。主题演讲之后,根据事先向所有与会者收集的调查问卷进行了富有成效的讨论。以下三人按以下顺序入选最佳海报展示奖,并获得了布鲁克公司颁发的奖品:每个分会场都评选出了最佳口头报告奖,并向以下人员颁发了 AFMBioMed-JMR 青年研究员奖:Kenichi Umeda(日本神奈川县)、Sabrina Horn(奥地利分子病理学研究所)和 Irma Custovic(法国勃艮第弗朗什-孔泰大学):此外,为了鼓励青年研究人员参加会议,会议还设立了 "青年研究人员差旅费奖",为以下九位研究人员提供每人最高 500 美元的差旅费:Irma Custovic(法国勃艮第弗朗什-孔泰大学)、You-Rong Lin(日本金泽大学)、Nelmary Roas-Escalona(芬兰阿尔托大学)、Klara Strobl(西班牙马德里自治大学)、Misato Iwashita(韩国脑研究所、冯玉珍(荷兰格罗宁根 Rijksuniversiteit Zernike 研究所)、Samuel Leitao(瑞士 EPFL)、Jonathan Roth(美国新泽西州立大学)和姚晓斌(德国耶拿 Friedrich Schiller 大学)。会议还在 2022 年 AFM 生物医学会议期间举办了为期半天的会前布鲁克研讨会和培训日活动。会议的一大亮点是参观了毗邻冈崎市的蒲郡市。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Molecular Recognition
Journal of Molecular Recognition 生物-生化与分子生物学
CiteScore
4.60
自引率
3.70%
发文量
68
审稿时长
2.7 months
期刊介绍: Journal of Molecular Recognition (JMR) publishes original research papers and reviews describing substantial advances in our understanding of molecular recognition phenomena in life sciences, covering all aspects from biochemistry, molecular biology, medicine, and biophysics. The research may employ experimental, theoretical and/or computational approaches. The focus of the journal is on recognition phenomena involving biomolecules and their biological / biochemical partners rather than on the recognition of metal ions or inorganic compounds. Molecular recognition involves non-covalent specific interactions between two or more biological molecules, molecular aggregates, cellular modules or organelles, as exemplified by receptor-ligand, antigen-antibody, nucleic acid-protein, sugar-lectin, to mention just a few of the possible interactions. The journal invites manuscripts that aim to achieve a complete description of molecular recognition mechanisms between well-characterized biomolecules in terms of structure, dynamics and biological activity. Such studies may help the future development of new drugs and vaccines, although the experimental testing of new drugs and vaccines falls outside the scope of the journal. Manuscripts that describe the application of standard approaches and techniques to design or model new molecular entities or to describe interactions between biomolecules, but do not provide new insights into molecular recognition processes will not be considered. Similarly, manuscripts involving biomolecules uncharacterized at the sequence level (e.g. calf thymus DNA) will not be considered.
期刊最新文献
Probing the Molecular Basis of Aminoacyl-Adenylate Affinity With Mycobacterium tuberculosis Leucyl-tRNA Synthetase Employing Molecular Dynamics, Umbrella Sampling Simulations and Site-Directed Mutagenesis. Issue Information Role of Circular RNA MMP9 in Glioblastoma Progression: From Interaction With hnRNPC and hnRNPA1 to Affecting the Expression of BIRC5 by Sequestering miR-149. Targeting Human Papillomavirus 33 E2 DNA Binding Domain With Polyphenols: Unveiling Interactions Through Biophysical and In Silico Methods. Toward Understanding the Mechanism of Client-Selective Small Molecule Inhibitors of the Sec61 Translocon.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1